DK92483A - 1alfa,2alfa,6beta,7beta,15beta,16beta-trimethylen-3-oxo-17alfa-pregn-4-en-21,17-carbolacton, dens fremstilling og anvendelse som laegemiddel - Google Patents

1alfa,2alfa,6beta,7beta,15beta,16beta-trimethylen-3-oxo-17alfa-pregn-4-en-21,17-carbolacton, dens fremstilling og anvendelse som laegemiddel Download PDF

Info

Publication number
DK92483A
DK92483A DK92483A DK92483A DK92483A DK 92483 A DK92483 A DK 92483A DK 92483 A DK92483 A DK 92483A DK 92483 A DK92483 A DK 92483A DK 92483 A DK92483 A DK 92483A
Authority
DK
Denmark
Prior art keywords
carbolacton
2alfa
15beta
17alfa
1alfa
Prior art date
Application number
DK92483A
Other languages
English (en)
Other versions
DK92483D0 (da
Inventor
Henry Laurent
Dieter Bittler
Rudolf Wiechert
Wolfgang Losert
Ekkehard Schillinger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK92483D0 publication Critical patent/DK92483D0/da
Publication of DK92483A publication Critical patent/DK92483A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK92483A 1982-04-13 1983-02-25 1alfa,2alfa,6beta,7beta,15beta,16beta-trimethylen-3-oxo-17alfa-pregn-4-en-21,17-carbolacton, dens fremstilling og anvendelse som laegemiddel DK92483A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823213962 DE3213962A1 (de) 1982-04-13 1982-04-13 1(alpha).2(alpha);6(beta).7(beta).15(beta).16(beta)-trimethylen-3-oxo-17(alpha)-pregn-4-en-21.17-carbolacton, dessen herstellung und verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
DK92483D0 DK92483D0 (da) 1983-02-25
DK92483A true DK92483A (da) 1983-10-14

Family

ID=6161018

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92483A DK92483A (da) 1982-04-13 1983-02-25 1alfa,2alfa,6beta,7beta,15beta,16beta-trimethylen-3-oxo-17alfa-pregn-4-en-21,17-carbolacton, dens fremstilling og anvendelse som laegemiddel

Country Status (6)

Country Link
EP (1) EP0091881A1 (da)
JP (1) JPS58188900A (da)
AU (1) AU1324583A (da)
DE (1) DE3213962A1 (da)
DK (1) DK92483A (da)
ES (1) ES8402318A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414508A1 (de) * 1984-04-13 1985-10-24 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrfach tritiierte steroid-20.17-spirolactone und ihre verwendung als tracersubstanzen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753979A (en) * 1971-12-06 1973-08-21 Merck & Co Inc Substituted 1,2alpha-methylene-6,7alpha-halomethylene-20-spirox-4-en-3-ones or 3-ols and acyl esters thereof
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2922500A1 (de) * 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta

Also Published As

Publication number Publication date
AU1324583A (en) 1984-10-11
DE3213962A1 (de) 1983-10-13
DK92483D0 (da) 1983-02-25
JPS58188900A (ja) 1983-11-04
EP0091881A1 (en) 1983-10-19
ES521420A0 (es) 1984-02-01
ES8402318A1 (es) 1984-02-01

Similar Documents

Publication Publication Date Title
DK520283D0 (da) Vandig,oral oploesning
FI842400L (fi) Naproxen- och naproxen-natriumtabletter, vilka frigoers kontrollerat.
DE3672982D1 (de) Kettengewirkte spitzen.
FI853913A0 (fi) Farmaceutiska foereningar som antracyklinglykosider.
DK381985D0 (da) 3-pyridylforbindelser, deres fremstilling og anvendelse som laegemiddel
ES516765A0 (es) Una tetrahidroftalimida.
DK143284D0 (da) Thiazolinderivater,deres fremstilling og anvendelse som laegemiddel
DK593883A (da) Substituerede phenylsulfonyloxybenzimidazolcarbaminater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
FI820245A7 (fi) Suippokaarirakenne.
ES524698A0 (es) Un procedimiento para preparar una beta-lactama.
FI834712A0 (fi) Vridfoerslutning foer smaelta raomaterial, speciellt metallsmaeltor
DE3463265D1 (de) N,n-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine
FI840600A0 (fi) Aktiveringsledning foer supraledande anordningar, speciellt magneter
NO861816L (no) Kjennemerke.
DK627684D0 (da) 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel
DK506183A (da) Hidtil ukendte carbacykliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
DK92483A (da) 1alfa,2alfa,6beta,7beta,15beta,16beta-trimethylen-3-oxo-17alfa-pregn-4-en-21,17-carbolacton, dens fremstilling og anvendelse som laegemiddel
DK403585D0 (da) Histargin-beslaegtede forbindelser, en fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
IT8621739A0 (it) Blocco del tipo a cassaforma.
ES2016553B3 (es) Un metodo para producir alfa,alfa-dimetil-delta-valerolactona.
NO822534L (no) Oxotienobenzooksepiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
DK238486A (da) 2,4-dichlor-5-nitro-thiazol, dens fremstilling og anvendelse som mikrobiocid
ES541400A0 (es) Una tableta fumigante
FI830992A7 (fi) 7- -aminoasyyli-3-kloorikefalosporiineja, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkeaineina.
DK54284D0 (da) Substituerede oximethre,deres fremstilling og anvendelse som skadedyrsbekaempelsesmiddel

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment